Alzheimer’s Disease-Related Dementia
Early Recognition and Treatment to Improve Patient Outcomes
Off-Label Policy

When an unlabeled use of a commercial product—or an investigational product not yet approved for any purpose—is discussed during an educational activity, the speaker is required to disclose that the product is not yet labeled for the use under discussion or to state that the product is still investigational.